Mark Elliott Brecher

Last updated

Mark Elliot Brecher is a physician specializing in pathology, in particular blood transfusion.

Contents

Biography

In 1982, Brecher earned a MD at the University of Chicago Pritzker School of Medicine; he also had his residency training in anatomic and clinical pathology there. He subsequently completed a blood banking and transfusion medicine fellowship at the Mayo Clinic.

Professional career

He was a member of the faculty of the Mayo Clinic Department of Laboratory Medicine and Pathology from 1988 to 1992, and then moved to the University of North Carolina as a member of the faculty and vice-chair in the Department of Pathology and Laboratory Medicine from 1992 to 2009. [1]

In 2009 he became the Chief Medical Officer for the Laboratory Corporation of America, while retaining a position as adjunct professor of pathology and laboratory medicine at the University of North Carolina. [2] In 2018, he retired and became an Emeritus Professor at the University of North Carolina.

Professional service

From 2001 to 2005 he chaired the United States Department of Health and Human Services (DHHS) Advisory Committee on Blood Safety and Availability. He served as the president of the American Society for Apheresis (2005 to 2006) and has received that society's ASFA Lecturer's award (2010), the Presidential award (2011) and the Morrison Memorial Lecture Award (2016). [3] In 2020, he received the Tibby Greenwalt Memorial award from the Association for the Advancement of Blood and Biotherapies (AABB). [4] His research and advocacy contributed to reducing the risk of bacterial contamination of blood products for transfusion. [5] [6]

Publications

His most cited, peer-reviewed publications are:

Related Research Articles

<span class="mw-page-title-main">Blood transfusion</span> Intravenous transference of blood products

Blood transfusion is the process of transferring blood products into a person's circulation intravenously. Transfusions are used for various medical conditions to replace lost components of the blood. Early transfusions used whole blood, but modern medical practice commonly uses only components of the blood, such as red blood cells, white blood cells, plasma, platelets, and other clotting factors.

Transfusion medicine is the branch of medicine that encompasses all aspects of the transfusion of blood and blood components including aspects related to hemovigilance. It includes issues of blood donation, immunohematology and other laboratory testing for transfusion-transmitted diseases, management and monitoring of clinical transfusion practices, patient blood management, therapeutic apheresis, stem cell collections, cellular therapy, and coagulation. Laboratory management and understanding of state and federal regulations related to blood products are also a large part of the field.

<span class="mw-page-title-main">Charles R. Drew</span> American surgeon and medical researcher (1904–1950)

Charles Richard Drew was an American surgeon and medical researcher. He researched in the field of blood transfusions, developing improved techniques for blood storage, and applied his expert knowledge to developing large-scale blood banks early in World War II. This allowed medics to save thousands of Allied forces' lives during the war. As the most prominent African American in the field, Drew protested against the practice of racial segregation in the donation of blood, as it lacked scientific foundation, and resigned his position with the American Red Cross, which maintained the policy until 1950.

<span class="mw-page-title-main">Platelet</span> Component of blood aiding in coagulation

Platelets or thrombocytes are a component of blood whose function is to react to bleeding from blood vessel injury by clumping, thereby initiating a blood clot. Platelets have no cell nucleus; they are fragments of cytoplasm derived from the megakaryocytes of the bone marrow or lung, which then enter the circulation. Platelets are found only in mammals, whereas in other vertebrates, thrombocytes circulate as intact mononuclear cells.

<span class="mw-page-title-main">Blood-borne disease</span> Medical condition

A blood-borne disease is a disease that can be spread through contamination by blood and other body fluids. Blood can contain pathogens of various types, chief among which are microorganisms, like bacteria and parasites, and non-living infectious agents such as viruses. Three blood-borne pathogens in particular, all viruses, are cited as of primary concern to health workers by the CDC-NIOSH: HIV, hepatitis B (HVB), & hepatitis C (HVC).

<span class="mw-page-title-main">Blood bank</span> Place where blood donations are collected

A blood bank is a center where blood gathered as a result of blood donation is stored and preserved for later use in blood transfusion. The term "blood bank" typically refers to a department of a hospital usually within a clinical pathology laboratory where the storage of blood product occurs and where pre-transfusion and blood compatibility testing is performed. However, it sometimes refers to a collection center, and some hospitals also perform collection. Blood banking includes tasks related to blood collection, processing, testing, separation, and storage.

<span class="mw-page-title-main">Blood donation</span> Blood withdrawal for use by another person via transfusion

A blood donation occurs when a person voluntarily has blood drawn and used for transfusions and/or made into biopharmaceutical medications by a process called fractionation. Donation may be of whole blood, or of specific components directly (apheresis). Blood banks often participate in the collection process as well as the procedures that follow it.

<span class="mw-page-title-main">Thrombocytopenia</span> Abnormally low levels of platelets in the blood

In hematology, thrombocytopenia is a condition characterized by abnormally low levels of platelets in the blood. Low levels of platelets in turn may lead to prolonged or excessive bleeding. It is the most common coagulation disorder among intensive care patients and is seen in a fifth of medical patients and a third of surgical patients.

<span class="mw-page-title-main">Apheresis</span> Medical techniques to separate one or more components of blood

Apheresis is a medical technology in which the blood of a person is passed through an apparatus that separates out one particular constituent and returns the remainder to the circulation. It is thus an extracorporeal therapy.

<span class="mw-page-title-main">Plateletpheresis</span> Method of collecting platelets from blood

Plateletpheresis is the process of collecting thrombocytes, more commonly called platelets, a component of blood involved in blood clotting. The term specifically refers to the method of collecting the platelets, which is performed by a device used in blood donation that separates the platelets and returns other portions of the blood to the donor. Platelet transfusion can be a life-saving procedure in preventing or treating serious complications from bleeding and hemorrhage in patients who have disorders manifesting as thrombocytopenia or platelet dysfunction. This process may also be used therapeutically to treat disorders resulting in extraordinarily high platelet counts such as essential thrombocytosis.

<span class="mw-page-title-main">Transfusion-related acute lung injury</span> Medical condition

Transfusion-related acute lung injury (TRALI) is the serious complication of transfusion of blood products that is characterized by the rapid onset of excess fluid in the lungs. It can cause dangerous drops in the supply of oxygen to body tissues. Although changes in transfusion practices have reduced the incidence of TRALI, it was the leading cause of transfusion-related deaths in the United States from fiscal year 2008 through fiscal year 2012.

<span class="mw-page-title-main">Platelet transfusion</span> Treatment for bleeding irregularities

Platelet transfusion, also known as platelet concentrate, is used to prevent or treat bleeding in people with either a low platelet count or poor platelet function. Often this occurs in people receiving cancer chemotherapy. Preventive transfusion is often done in those with platelet levels of less than 10 x 109/L. In those who are bleeding transfusion is usually carried out at less than 50 x 109/L. Blood group matching (ABO, RhD) is typically recommended before platelets are given. Unmatched platelets, however, are often used due to the unavailability of matched platelets. They are given by injection into a vein.

Transfusion-related immunomodulation (TRIM) refers to the transient depression of the immune system following transfusion of blood products. This effect has been recognized in groups of individuals who have undergone kidney transplantation or have had multiple miscarriages. Some research studies have shown that, because of this immune depression, blood transfusions increase the risk of infections and cancer recurrence. However, other studies have not shown these differences and the degree of impact transfusion has on infection and tumor recurrence is not well understood. The Blood Products Advisory Committee of the Food and Drug Administration recommends that all transfused blood products undergo leukocyte reduction in order to offset the contribution of donor white blood cells to immune suppression.

The MNS antigen system is a human blood group system based upon two genes on chromosome 4. There are currently 50 antigens in the system, but the five most important are called M, N, S, s, and U.

<span class="mw-page-title-main">P1PK blood group system</span> Human blood group system

P1PK is a human blood group system based upon the A4GALT gene on chromosome 22. The P antigen was first described by Karl Landsteiner and Philip Levine in 1927. The P1PK blood group system consists of three glycosphingolipid antigens: Pk, P1 and NOR. In addition to glycosphingolipids, terminal Galα1→4Galβ structures are present on complex-type N-glycans. The GLOB antigen is now the member of the separate GLOB (globoside) blood group system.

<span class="mw-page-title-main">Medical laboratory</span> Principles of management with special reference to medical science

A medical laboratory or clinical laboratory is a laboratory where tests are conducted out on clinical specimens to obtain information about the health of a patient to aid in diagnosis, treatment, and prevention of disease. Clinical medical laboratories are an example of applied science, as opposed to research laboratories that focus on basic science, such as found in some academic institutions.

Carter BloodCare is a 501(c)(3) nonprofit organization headquartered in Bedford, Texas. Carter BloodCare currently provides more than 440,000 blood products annually to over 200 hospitals serving patients in more than 50 counties across North, Central and East Texas. One of the largest blood centers in operation in the United States, Carter BloodCare’s mission is “we save lives by making transfusion possible.”.

Frederic Duran i Jordà was a Spanish medical doctor, pioneer hematology and hemotherapy. He created the first transfusion service in the world in Barcelona in 1936 at the beginning of the Spanish Civil War. Previously there were blood banks, where donated blood to be transfused was stored. Dr. Duran i Jordà created a methodology that would serve to collect massive blood donations and be transfused distance, in this case the front lines of the Spanish Civil War. This method was subsequently applied in World War II.

George William Gregory Bird was a British medical doctor, academic, researcher and haematologist known for his expertise in the fields of blood transfusion and immunohaematology. He founded the Department of Transfusion Medicine at the Armed Forces Medical College, Pune and was inducted into their Hall of Fame in 2010. A winner of the Karl Landsteiner Memorial Prize and Morten Grove Rasmussen Memorial Award of the American Association of Blood Banks, Gregory Bird was honoured by the Government of India in 1963, with the award of Padma Shri, the fourth highest Indian civilian award for his services to the nation.

Dana Devine is a blood transfusion researcher and the president of AABB. She was the editor-in-chief of Vox Sanguinis from 2012 to 2020. Devine is also the Chief Scientist at Canadian Blood Services and the director of the Centre for Blood Research at the University of British Columbia. In 2015, she was elected as a fellow of the Canadian Academy of Health Sciences. In 2022, she was elected as the President of the Biomedical Excellence for Safer Transfusion Collaborative.

References

  1. History of the UNC Pathology Department "History of the Department". Archived from the original on 2011-02-23. Retrieved 2011-09-11.
  2. "Brecher". Archived from the original on 2012-03-25. Retrieved 2011-09-11.
  3. "About ASFA - American Society for Apheresis (ASFA)".
  4. "List of Past AABB Awards Recipients".
  5. Yomtovian, R (2004). "Bacterial contamination of blood: lessons from the past and road map for the future". Transfusion. 44 (3): 450–60. doi:10.1111/j.1537-2995.2003.030342.x. PMID   14996205. S2CID   29833401.
  6. "Bacterial Contamination of Platelets for Transfusion".
  7. 1 2 3 4 5 "Google Scholar Author page - ME Berecher" . Retrieved 2021-10-01.